American International Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-35,594
| Closed | -$56.6K | – | 3105 |
|
|
2023
Q1 | $56.6K | Buy |
35,594
+707
| +2% | +$1.12K | ﹤0.01% | 2672 |
|
|
2022
Q4 | $217K | Buy |
34,887
+3,263
| +10% | +$20.3K | ﹤0.01% | 2094 |
|
|
2022
Q3 | $212K | Buy |
31,624
+2,107
| +7% | +$14.1K | ﹤0.01% | 2124 |
|
|
2022
Q2 | $188K | Buy |
29,517
+839
| +3% | +$5.34K | ﹤0.01% | 2221 |
|
|
2022
Q1 | $133K | Buy |
28,678
+14,290
| +99% | +$66.3K | ﹤0.01% | 2465 |
|
|
2021
Q4 | $72K | Buy |
14,388
+20
| +0.1% | +$100 | ﹤0.01% | 2844 |
|
|
2021
Q3 | $173K | Sell |
14,368
-342
| -2% | -$4.12K | ﹤0.01% | 2508 |
|
|
2021
Q2 | $311 | Sell |
14,710
-379
| -3% | -$8 | ﹤0.01% | 2231 |
|
|
2021
Q1 | $423 | Buy |
15,089
+40
| +0.3% | +$1 | ﹤0.01% | 1923 |
|
|
2020
Q4 | $391 | Sell |
15,049
-431
| -3% | -$11 | ﹤0.01% | 1885 |
|
|
2020
Q3 | $575K | Sell |
15,480
-353
| -2% | -$13.1K | ﹤0.01% | 1533 |
|
|
2020
Q2 | $812K | Buy |
15,833
+849
| +6% | +$43.5K | ﹤0.01% | 1331 |
|
|
2020
Q1 | $472K | Sell |
14,984
-867
| -5% | -$27.3K | ﹤0.01% | 1469 |
|
|
2019
Q4 | $945K | Buy |
15,851
+106
| +0.7% | +$6.32K | ﹤0.01% | 1361 |
|
|
2019
Q3 | $577K | Sell |
15,745
-109
| -0.7% | -$3.99K | ﹤0.01% | 1583 |
|
|
2019
Q2 | $738K | Buy |
15,854
+1,263
| +9% | +$58.8K | ﹤0.01% | 1490 |
|
|
2019
Q1 | $586K | Sell |
14,591
-473
| -3% | -$19K | ﹤0.01% | 1616 |
|
|
2018
Q4 | $693K | Sell |
15,064
-116
| -0.8% | -$5.34K | ﹤0.01% | 1481 |
|
|
2018
Q3 | $674K | Buy |
15,180
+273
| +2% | +$12.1K | ﹤0.01% | 1694 |
|
|
2018
Q2 | $584K | Buy |
14,907
+3,846
| +35% | +$151K | ﹤0.01% | 1727 |
|
|
2018
Q1 | $800K | Sell |
11,061
-369
| -3% | -$26.7K | ﹤0.01% | 1406 |
|
|
2017
Q4 | $753K | Buy |
11,430
+173
| +2% | +$11.4K | ﹤0.01% | 1538 |
|
|
2017
Q3 | $564K | Buy |
11,257
+2,001
| +22% | +$100K | ﹤0.01% | 1692 |
|
|
2017
Q2 | $428K | Buy |
9,256
+442
| +5% | +$20.4K | ﹤0.01% | 1806 |
|
|
2017
Q1 | $311K | Buy |
8,814
+584
| +7% | +$20.6K | ﹤0.01% | 1907 |
|
|
2016
Q4 | $103K | Sell |
8,230
-22
| -0.3% | -$275 | ﹤0.01% | 2590 |
|
|
2016
Q3 | $114K | Buy |
8,252
+12
| +0.1% | +$166 | ﹤0.01% | 2528 |
|
|
2016
Q2 | $81.4K | Buy |
8,240
+456
| +6% | +$4.51K | ﹤0.01% | 2754 |
|
|
2016
Q1 | $132K | Buy |
7,784
+100
| +1% | +$1.7K | ﹤0.01% | 3162 |
|
|
2015
Q4 | $171K | Sell |
7,684
-14
| -0.2% | -$312 | ﹤0.01% | 2996 |
|
|
2015
Q3 | $182K | Buy |
7,698
+9
| +0.1% | +$213 | ﹤0.01% | 2917 |
|
|
2015
Q2 | $629K | Buy |
7,689
+3,830
| +99% | +$313K | ﹤0.01% | 1980 |
|
|
2015
Q1 | $357K | Sell |
3,859
-1
| -0% | -$93 | ﹤0.01% | 2442 |
|
|
2014
Q4 | $156K | Buy |
3,860
+823
| +27% | +$33.3K | ﹤0.01% | 3167 |
|
|
2014
Q3 | $74.3K | Sell |
3,037
-3
| -0.1% | -$73 | ﹤0.01% | 3771 |
|
|
2014
Q2 | $48.2K | Sell |
3,040
-73
| -2% | -$1.16K | ﹤0.01% | 3974 |
|
|
2014
Q1 | $47.1K | Buy |
3,113
+75
| +2% | +$1.13K | ﹤0.01% | 3864 |
|
|
2013
Q4 | $41.7K | Buy |
+3,038
| New | +$41.7K | ﹤0.01% | 3849 |
|